We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > combination therapy

News List

Combination therapy suppresses HIV-like virus in primates europeanpharmaceuticalreview
March 08, 2018
Broadly neutralising antibody treatment may target viral reservoir in monkeys…
FDA grants breast cancer approval to Roche's Perjeta/Herceptin combo therapy pharmafile
December 22, 2017
Roche has announced that the FDA has granted approval to Perjeta in combination with Herceptin and a Perjeta-based) chemotherapy regimen for the adjuvant treatment of HER2-positive early breast cancer which is at a high chance of recurrence.
Combined therapies increase side effects for patients with advanced breast cancer europeanpharmaceuticalreview
November 06, 2017
Patients with advanced breast cancer who are treated with a combination of drugs are at increased risk of suffering adverse side effects…
Merck Announces New Phase 2 Data on Investigational Triple Combination Therapy MK-3682B for Chronic firstwordpharma
April 24, 2017
indings Presented at The International Liver Congress™ 2017 Show High Rates of Sustained Virologic Response (SVR12) in Genotype 1 Patients for Whom Direct-Acting Antiviral Therapy Had Previously Failed
Launch of Utibron Neohaler in the US cphi-online
April 05, 2017
Represents the latest combination therapy now available for the millions of patients living with COPD in the US.

Previous page 1 2 Next page